Atlas Trials

A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database

Clinical trial NCT05421442 · COMPLETED

Trial details

NCT number
NCT05421442
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)
Start date
2019-06-13
Primary completion
2025-08-22
Enrollment
38396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.